Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
98M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
6.79M
-
Shares change
-
+1.01M
-
Total reported value, excl. options
-
$33.1M
-
Value change
-
+$4.92M
-
Number of buys
-
15
-
Number of sells
-
-6
-
Price
-
$4.88
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q2 2021
26 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q2 2021.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.79M shares
of 98M outstanding shares and own 6.93% of the company stock.
Largest 10 shareholders include FMR LLC (1.68M shares), FEDERATED HERMES, INC. (1.62M shares), Alyeska Investment Group, L.P. (1.27M shares), VANGUARD GROUP INC (595K shares), Ikarian Capital, LLC (300K shares), BlackRock Inc. (225K shares), DIMENSIONAL FUND ADVISORS LP (221K shares), Telemetry Investments, L.L.C. (179K shares), RENAISSANCE TECHNOLOGIES LLC (176K shares), and TWO SIGMA ADVISERS, LP (120K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.